make progress share loss still problem
view continu progress cl evidenc organ growth
quarter encourag manag commit
increas ad spend level though concern requir
given continu deterior share trend increas competit
drive cost growth space believ limit ep
upsid near term reiter sector perform
takeaway quarter posit organ sale growth
volume price underli basi flat sequenti
march expect organ sale growth
high end previous commun rang gross
margin expand bp driven cost save bp
higher price bp off-set raw material/packag cost incl fx
transact bp first time five quarter gross
margin expand manag continu guid expans
full year impli acceler next two quarter
compani continu reinvest behind brand via advertis spend
quarter sale bp y/i encourag
expect take time manifest share stabil neg
ytd global toothpast share manual toothbrush share
impli continu share loss quarter attribut
heighten competit activ gsk/pg local
expect guidanc remain unchang expect materi
chang guidanc year-end think manag flex
over-deliv ep could slightli improv outlook low-
to-mid singl digit though expect new ceo noel wallac reinvest
upsid given compani current focu organ growth build
adjust estim maintain ep estim
vs reiter guidanc mid-singl digit believ increas ad
spend support organ growth rais estim
bp updat guidanc high-end maintain
price target
long-term view believ colgat path
valuat
outperform market easi one requir signific
step-up investmentsa realiti think manag realiz
embrac cost growth continu creep higher cpg
believ dynam continu limit upsid ep next
coupl year coupl fx headwind see path forward
materi upsid stock near term especi consid
cl price-to-earnings premium xlp near high
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
sale deceler amid macro volatil heighten
competit global particularli emerg market
latin america account colgat profit
commod cost fx also add uncertainti stori
expans global growth effici program
initi compani expect achiev annual
save expect three-
four-year cash payback averag after-tax rate
return greater given compani execut track
record confid like abl come
high end target
continu macro headwind latin america
colgat gener profit declin
emerg market
currenc could materi impact compani top
line profit increas competit activ
oral care colgat core market especi could
hinder organ sale growth share gain
bloomberg capit market estim upside/downside/target
dcf-driven base case scenario valu cl share
assum top-lin compound-annual-growth-rate peak profit margin
valu colgat assum wacc
long run termin growth rate
dcf-driven upsid scenario valu cl share
upsid case assum top-lin compound-annual-growth-rate peak
profit margin scenario colgat
regain share behind new innov along whitespac
expans upsid compani announc cost
save valu colgat upsid case assum wacc
long run termin growth rate
dcf-driven downsid scenario valu cl share
downsid case assum top-lin compound-annual-growth-rate
peak profit margin
scenario colgat face stepped-up competit
competitor emerg market unabl meet cost-
save expect valu colgat downsid case
assum wacc long run termin growth
rate
dcf-driven base case scenario valu cl share assum top-lin compound-annual-growth-rate
peak profit margin valu colgat assum wacc
long run termin growth rate price target support sector perform
risk rate price target
volatil emerg market currenc could materi impact compani
top line profit estim colgat currenc exposur select currenc
brazilian real euro mexican peso venezuelan bolivar australian
dollar british pound
volatil input cost includ supplier cost raw packag materi commod
resin tropic oil essenti oil tallow poultri corn soybean subject
wide price variat increas cost avail commod
cost energi transport necessari servic may advers affect
profit margin compani unabl pass along higher cost form price
increas otherwis achiev cost effici manufactur distribut
increas competit activ oral care colgat core market especi
could hinder organ sale growth share gain respond competit activ often
take manag time increment expens price reduct
colgate-palmol manufactur oral care person care home care product
global oral care offer includ toothpast toothbrush mouth wash dental floss
pharmaceut product primarili compani colgat brand person
care segment compani sell hand bodi soap shower gel deodor hair care
product variou brand includ palmol irish spring home care segment
compris laundri dishwash deterg household cleaner palmol
ajax brand compani also market pet food hill segment hill
scienc diet brand name compani found headquart new
ms except ep ratio
good sold
net incom attribut cl
sourc capit market estim compani document
